LOXL2 and prostate cancer: A recent report claimed that miR-29c together with other five miRNAs such as miR-29a, miR-29b, miR-26a, miR-26b and miR-218 can control the expression of metastasis-promoting LOXL2 gene during the development of prostate cancer [49].